← FDA DRUG APPROVALS

FDA ANDA · ANDA076703

DESMOPRESSIN ACETATE

Sponsor: APOTEX

APPLICATION
ANDA076703
TYPE
ANDA
ORIGINAL APPROVAL
2005-01-27
LATEST ACTION
2019-10-24
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Prescription

Products

DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION)Prescription
DESMOPRESSIN ACETATE 0.01MG/SPRAY · SPRAY, METERED · NASAL

Approval history

2019-10-24Labeling · Supplement 27 · standardAP
2019-10-24Labeling · Supplement 31 · standardAP
2009-08-20Labeling · Supplement 17AP
2008-03-11Labeling · Supplement 14AP
2007-05-23Labeling · Supplement 10AP
2006-12-03Labeling · Supplement 9AP
2006-03-02Labeling · Supplement 2AP
2005-01-27OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →